Joyita Dutta, PhD
Research Awards Nationwide Recipient (2014-2016)
Massachusetts General Hospital, Boston, MA
Using PET/MRI Images in Late-Stage Lung Cancer Treatment
Advanced non-small cell lung cancer (NSCLC) has only a 4% 5-year survival rate. Determining an optimal treatment plan for patients with late stage non-small cell lung cancer would help to improve the currently low probability of patient survival. Using new and emerging PET/MRI technology, the researchers hope to be able to first reconstruct a high quality 3D PET image of tumors from the motion information of the MRI and then correlate it with the actual outcome in patients. It is hoped that the motion-compensated PET/MRI image could assist in guiding treatment plans for non-small cell lung cancer.
Sign up for the latest lung health news delivered right to your inbox.
Join more than 500,000 people who receive research updates, inspiring stories, health information and more.